Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment

NCT02077868 is registered in ClinicalTrials.gov with Mologen AG as lead sponsor.

NCT NCT02077868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02077868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment
Lead sponsor
Mologen AG
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2014
Completion date
May 31, 2020
Enrollment
540 (estimated)
Sites
125

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer